abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING: a) A DISPERSION OF MACROLIDE SOLID SELECTED FROM A DERIVATIVE OF RAPAMYCIN 40-O- (2-HYDROXY) ETHYL-RAPAMYCIN; b) A DISINTEGRANT; c) FROM 1% TO 5% OF COLLOIDAL SILICON DIOXIDE BY WEIGHT. THE COMPOSITION IS IN THE FORM OF A DISPERSIBLE TABLET AND HAS A DISINTEGRATION TIME OF 90 SECONDS / FK 506 |